Publication details
Studie MARINER
| Title in English | MARINER Study |
|---|---|
| Authors | |
| Year of publication | 2019 |
| Type | Article in Periodical |
| Magazine / Source | Remedia |
| MU Faculty or unit | |
| Citation | |
| web | http://www.remedia.cz/Archiv-rocniku/Rocnik-2019/2-2019/e-2Fq-2Jw.magissue.aspx?Page=1 |
| Keywords | risk; thrombosis; embolism; rivaroxaban; clinical study |
| Description | The MARINER study was designed to optimise the benefit/risk profile of several week administration of rivaroxaban for prevention of deep venous thrombosis , non fatal or fatal pulmonary embolism. Rivaroxaban did not influence the primary endpoint. There was a beneficial trend in patients without renal insuficiency. The risk of bleeding was low in the whole study. |
| Related projects: |